Update to Interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection : PrEP for injecting drug users
Public Domain
-
June 14, 2013
-
File Language:
English
Details
-
Journal Article:Morbidity and Mortality Weekly Report (MMWR)
-
Personal Author:
-
Corporate Authors:
-
Description:On June 12, 2013, the Thailand Ministry of Health and CDC published results from a randomized controlled trial of a daily oral dose of 300 mg of tenofovir disoproxil fumarate (TDF) that showed efficacy in reducing the acquisition of human immunodeficiency virus (HIV) infection among injecting drug users (IDUs) (1). Based on these findings, CDC recommends that preexposure prophylaxis (PrEP) be considered as one of several prevention options for persons at very high risk for HIV acquisition through the injection of illicit drugs.
PMID: 23760186
-
Subjects:
-
Source:MMWR. Morbidity and mortality weekly report. 2013 Jun 14; 62(23):463-5
-
Series:
-
ISSN:0149-2195 (print) ; 1545-861X (digital)
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Pages in Document:3 pdf pages
-
Volume:62
-
Issue:23
-
Collection(s):
-
Main Document Checksum:urn:sha-512:ee25e2f89f6113e6637b0741f0c4b378b67a0b47c00b76977b5cd0cba27ce858a58d238d4bf4566683f0431be52a686e4e23bd60f11582ae486a4f14652517b0
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like